Page last updated: 2024-08-23

butaclamol and Schizophrenia

butaclamol has been researched along with Schizophrenia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (75.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, XF; Zavitsanou, K	1
Ban, TA; Lehmann, HE; Nestoros, JN	1
Clark, ML; Costiloe, JP; Fulkerson, FG; Paredes, A; Wood, F	1
Ackenheil, M; Bondy, B; Elbers, R; Fröhler, M	1

Trials

2 trial(s) available for butaclamol and Schizophrenia

Article	Year
Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial. International pharmacopsychiatry, 1978, Volume: 13, Issue:3 Topics: Adult; Butaclamol; Clinical Trials as Topic; Dibenzocycloheptenes; Double-Blind Method; Electrocardiography; Eye Manifestations; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Time Factors	1978
Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design. Diseases of the nervous system, 1977, Volume: 38, Issue:11 Topics: Adolescent; Adult; Basal Ganglia Diseases; Butaclamol; Chronic Disease; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Schizophrenia; Time Factors	1977

Article

Year

Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial.

International pharmacopsychiatry, 1978, Volume: 13, Issue:3

Topics: Adult; Butaclamol; Clinical Trials as Topic; Dibenzocycloheptenes; Double-Blind Method; Electrocardiography; Eye Manifestations; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Time Factors

1978

Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design.

Diseases of the nervous system, 1977, Volume: 38, Issue:11

Topics: Adolescent; Adult; Basal Ganglia Diseases; Butaclamol; Chronic Disease; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Schizophrenia; Time Factors

1977

Other Studies

2 other study(ies) available for butaclamol and Schizophrenia

Article	Year
Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study. Neuroscience, 2002, Volume: 109, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Binding Sites; Binding, Competitive; Butaclamol; Down-Regulation; Gyrus Cinguli; Haloperidol; Humans; Mianserin; Middle Aged; Neurons; Neurotransmitter Agents; Radioligand Assay; Receptors, Neurotransmitter; Risperidone; Schizophrenia; Spiperone; Tritium	2002
Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia? Psychiatry research, 1985, Volume: 15, Issue:1 Topics: Acute Disease; Adult; B-Lymphocytes; Binding Sites; Butaclamol; Butyrophenones; Female; Humans; Lymphocytes; Male; Schizophrenia; Spiperone; T-Lymphocytes	1985

Article

Year

Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study.

Neuroscience, 2002, Volume: 109, Issue:4

Topics: Adult; Aged; Antipsychotic Agents; Binding Sites; Binding, Competitive; Butaclamol; Down-Regulation; Gyrus Cinguli; Haloperidol; Humans; Mianserin; Middle Aged; Neurons; Neurotransmitter Agents; Radioligand Assay; Receptors, Neurotransmitter; Risperidone; Schizophrenia; Spiperone; Tritium

2002

Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?

Psychiatry research, 1985, Volume: 15, Issue:1

Topics: Acute Disease; Adult; B-Lymphocytes; Binding Sites; Butaclamol; Butyrophenones; Female; Humans; Lymphocytes; Male; Schizophrenia; Spiperone; T-Lymphocytes

1985